- Home
- MPAA vs BDTX Comparison
MPAA vs BDTX Comparison
Compare MPAA & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPAA
- BDTX
- Stock Information
- Founded
- MPAA 1968
- BDTX 2014
- Country
- MPAA United States
- BDTX United States
- Employees
- MPAA N/A
- BDTX N/A
- Industry
- MPAA Auto Parts:O.E.M.
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MPAA Consumer Discretionary
- BDTX Health Care
- Exchange
- MPAA Nasdaq
- BDTX Nasdaq
- Market Cap
- MPAA 188.9M
- BDTX 181.4M
- IPO Year
- MPAA 1994
- BDTX 2020
- Fundamental
- Price
- MPAA $12.14
- BDTX $2.97
- Analyst Decision
- MPAA
- BDTX Strong Buy
- Analyst Count
- MPAA 0
- BDTX 6
- Target Price
- MPAA N/A
- BDTX $14.83
- AVG Volume (30 Days)
- MPAA 279.2K
- BDTX 1.3M
- Earning Date
- MPAA 08-07-2025
- BDTX 08-05-2025
- Dividend Yield
- MPAA N/A
- BDTX N/A
- EPS Growth
- MPAA N/A
- BDTX N/A
- EPS
- MPAA N/A
- BDTX 0.09
- Revenue
- MPAA $757,354,000.00
- BDTX $70,000,000.00
- Revenue This Year
- MPAA $7.74
- BDTX N/A
- Revenue Next Year
- MPAA $5.00
- BDTX N/A
- P/E Ratio
- MPAA N/A
- BDTX $33.71
- Revenue Growth
- MPAA 5.53
- BDTX N/A
- 52 Week Low
- MPAA $5.16
- BDTX $1.20
- 52 Week High
- MPAA $12.72
- BDTX $6.75
- Technical
- Relative Strength Index (RSI)
- MPAA 60.40
- BDTX 59.01
- Support Level
- MPAA $10.51
- BDTX $3.02
- Resistance Level
- MPAA $11.70
- BDTX $3.28
- Average True Range (ATR)
- MPAA 0.44
- BDTX 0.19
- MACD
- MPAA 0.02
- BDTX 0.00
- Stochastic Oscillator
- MPAA 77.99
- BDTX 59.41
About MPAA Motorcar Parts of America Inc.
Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard part in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.